866-997-4948(US-Canada Toll Free)

Biomoda, Inc. (BMOD) - Product Pipeline Analysis

Published By :

GlobalData

Published Date : Nov 2012

Category :

Surgical Equipment

No. of Pages : 68 Pages


Biomoda, Inc. (Biomoda) is a cancer diagnostics company, based in the US. It develops and manufactures in-vitro test for the early detection of lung cancer. The company develops assays, or tests, to detect cancer. These assays are performed in clinical reference laboratories using body-fluid samples. The companys main product, trademarked under the name CyPath, is an assay for the detection of early-stage lung cancer. Biomoda develops assays or tests to detect cancer and its product portfolio consists of reagents for diagnosing cancer in tissue specimens and porphyrins. The company is developing vaccines for diseases related to breast, circulating tumor cells (CTC), cervical, and bladder, colorectal, oral, and prostate cancers. It operates as a subsidiary of Biomoda Holdings, Inc. Biomoda is headquartered in Albuquerque, New Mexico, the US.

This report is a source for data, analysis and actionable intelligence on the Biomoda, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalDatas team of industry experts.

Scope

  • Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
  • Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
  • Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
  • Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
  • Data on relevant clinical trials and product patent details, wherever applicable.
  • Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Buy

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.
  • Design and develop your product development, marketing and sales strategies.
  • Exploit M&A opportunities by identifying market players with the most innovative pipeline.
  • Develop market-entry and market expansion strategies.
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Develop competition strategies by identifying the status and likely launch of your competitors pipeline products through review of the clinical trials, stage and phase of development, etc.Which are the next high-value products that your competitor would add in its portfolio? identify, understand and capitalize.
Table of Content

Table of Contents 2
List of Tables 3
List of Figures 5

Key Facts 6
Biomoda, Inc. - Major Products and Services 7
Biomoda, Inc. Pipeline Products by Equipment Type 8
Biomoda, Inc. Pipeline Products by Development Stage 10
Biomoda, Inc. Pipeline Products by Therapy Area 12
Biomoda, Inc. Pipeline Products by Trial Phase 14
Biomoda, Inc. Pipeline Products by Milestone Summary 16
CyPath Diagnostic Assay - Bladder Cancer 18
CyPath Diagnostic Assay - Bladder Cancer Product Status 18
CyPath Diagnostic Assay - Bladder Cancer Product Description 18
CyPath Diagnostic Assay - Bladder Cancer Product Patent Details 18
CyPath Diagnostic Assay - Breast Cancer 29
CyPath Diagnostic Assay - Breast Cancer Product Status 29
CyPath Diagnostic Assay - Breast Cancer Product Description 29
CyPath Diagnostic Assay - Breast Cancer Product Patent Details 29
CyPath Diagnostic Assay - Cervical Cancer 35
CyPath Diagnostic Assay - Cervical Cancer Product Status 35
CyPath Diagnostic Assay - Cervical Cancer Product Description 35
CyPath Diagnostic Assay - Cervical Cancer Product Patent Details 35
CyPath Diagnostic Assay - Colorectal Cancer 41
CyPath Diagnostic Assay - Colorectal Cancer Product Status 41
CyPath Diagnostic Assay - Colorectal Cancer Product Description 41
CyPath Diagnostic Assay - Colorectal Cancer Product Patent Details 41
CyPath Diagnostic Assay - Lung Cancer 47
CyPath Diagnostic Assay - Lung Cancer Product Status 47
CyPath Diagnostic Assay - Lung Cancer Product Description 47
CyPath Diagnostic Assay - Lung Cancer Product Milestone 47
CyPath Diagnostic Assay - Lung Cancer Clinical Trial 48
CyPath Diagnostic Assay - Lung Cancer Product Patent Details 50
CyPath Diagnostic Assay - Oral Cancer 56
CyPath Diagnostic Assay - Oral Cancer Product Status 56
CyPath Diagnostic Assay - Oral Cancer Product Description 56
CyPath Diagnostic Assay - Oral Cancer Product Patent Details 56
Biomoda, Inc. - Key Competitors 62
Biomoda, Inc. - Key Employees 63
Biomoda, Inc. - Locations And Subsidiaries 64
Head Office 64
Recent Developments 65
Biomoda, Inc., Recent Developments 65
Jan 24, 2012: Biomoda Receives European Patent Application For CyPath Technology 65
Aug 02, 2011: Biomoda Secures EPO Notification On Patent Application 65
Jul 06, 2011: Biomoda Receives Japan Patent Approval 65
Jun 14, 2011: Biomoda Receives Patent Expanding Use Of CyPath Assay 66
May 17, 2011: Biomoda Expands IP Portfolio With Canadian Patent, Trademark Protection In EU 66
Mar 15, 2011: Biomoda Reports Optimization Research For CyPath Assay 66

Appendix 68
Methodology 68
About GlobalData 68
Contact Us 68
Disclaimer 68

List of Table


Biomoda, Inc., Key Facts 1
Biomoda, Inc. Key Pipeline Products by Equipment Type 1
Biomoda, Inc. Key Pipeline Products by Therapy Area 1
Biomoda, Inc. Key Pipeline Products by Development Stage 1
Biomoda, Inc. Key Pipeline Products by Trial Phase 1
Biomoda, Inc., Key Facts 6
Biomoda, Inc., Major Products and Services 7
Biomoda, Inc. Number of Pipeline Products by Equipment Type 8
Biomoda, Inc. Pipeline Products by Equipment Type 9
Biomoda, Inc. Number of Pipeline Products by Development Stage 10
Biomoda, Inc. Pipeline Products by Development Stage 11
Biomoda, Inc. Number of Pipeline Products by Therapy Area 12
Biomoda, Inc. Pipeline Products by Therapy Area 13
Biomoda, Inc. Number of Pipeline Products by Trial Phase 14
Biomoda, Inc. Pipeline Products by Trial Phase 15
Biomoda, Inc. Number of Pipeline Products By Milestone Summary 16
Biomoda, Inc. Pipeline Products by Milestone Summary 17
CyPath Diagnostic Assay - Bladder Cancer - Product Status 18
CyPath Diagnostic Assay - Bladder Cancer - Product Description 18
CyPath Diagnostic Assay - Bladder Cancer - Patent Details1 18
CyPath Diagnostic Assay - Bladder Cancer - Patent Details2 19
CyPath Diagnostic Assay - Bladder Cancer - Patent Details3 19
CyPath Diagnostic Assay - Bladder Cancer - Patent Details4 20
CyPath Diagnostic Assay - Bladder Cancer - Patent Details5 20
CyPath Diagnostic Assay - Bladder Cancer - Patent Details6 21
CyPath Diagnostic Assay - Bladder Cancer - Patent Details7 21
CyPath Diagnostic Assay - Bladder Cancer - Patent Details8 22
CyPath Diagnostic Assay - Bladder Cancer - Patent Details9 22
CyPath Diagnostic Assay - Bladder Cancer - Patent Details10 23
CyPath Diagnostic Assay - Bladder Cancer - Patent Details11 24
CyPath Diagnostic Assay - Bladder Cancer - Patent Details12 24
CyPath Diagnostic Assay - Bladder Cancer - Patent Details13 25
CyPath Diagnostic Assay - Bladder Cancer - Patent Details14 25
CyPath Diagnostic Assay - Bladder Cancer - Patent Details15 26
CyPath Diagnostic Assay - Bladder Cancer - Patent Details16 26
CyPath Diagnostic Assay - Bladder Cancer - Patent Details17 27
CyPath Diagnostic Assay - Bladder Cancer - Patent Details18 27
CyPath Diagnostic Assay - Bladder Cancer - Patent Details19 28
CyPath Diagnostic Assay - Breast Cancer - Product Status 29
CyPath Diagnostic Assay - Breast Cancer - Product Description 29
CyPath Diagnostic Assay - Breast Cancer - Patent Details1 29
CyPath Diagnostic Assay - Breast Cancer - Patent Details2 30
CyPath Diagnostic Assay - Breast Cancer - Patent Details3 30
CyPath Diagnostic Assay - Breast Cancer - Patent Details4 31
CyPath Diagnostic Assay - Breast Cancer - Patent Details5 31
CyPath Diagnostic Assay - Breast Cancer - Patent Details6 32
CyPath Diagnostic Assay - Breast Cancer - Patent Details7 32
CyPath Diagnostic Assay - Breast Cancer - Patent Details8 33
CyPath Diagnostic Assay - Breast Cancer - Patent Details9 33
CyPath Diagnostic Assay - Breast Cancer - Patent Details10 34
CyPath Diagnostic Assay - Cervical Cancer - Product Status 35
CyPath Diagnostic Assay - Cervical Cancer - Product Description 35
CyPath Diagnostic Assay - Cervical Cancer - Patent Details1 35
CyPath Diagnostic Assay - Cervical Cancer - Patent Details2 36
CyPath Diagnostic Assay - Cervical Cancer - Patent Details3 36
CyPath Diagnostic Assay - Cervical Cancer - Patent Details4 37
CyPath Diagnostic Assay - Cervical Cancer - Patent Details5 37
CyPath Diagnostic Assay - Cervical Cancer - Patent Details6 38
CyPath Diagnostic Assay - Cervical Cancer - Patent Details7 38
CyPath Diagnostic Assay - Cervical Cancer - Patent Details8 39
CyPath Diagnostic Assay - Cervical Cancer - Patent Details9 39
CyPath Diagnostic Assay - Colorectal Cancer - Product Status 41
CyPath Diagnostic Assay - Colorectal Cancer - Product Description 41
CyPath Diagnostic Assay - Colorectal Cancer - Patent Details1 41
CyPath Diagnostic Assay - Colorectal Cancer - Patent Details2 42
CyPath Diagnostic Assay - Colorectal Cancer - Patent Details3 42
CyPath Diagnostic Assay - Colorectal Cancer - Patent Details4 43
CyPath Diagnostic Assay - Colorectal Cancer - Patent Details5 43
CyPath Diagnostic Assay - Colorectal Cancer - Patent Details6 44
CyPath Diagnostic Assay - Colorectal Cancer - Patent Details7 44
CyPath Diagnostic Assay - Colorectal Cancer - Patent Details8 45
CyPath Diagnostic Assay - Colorectal Cancer - Patent Details9 45
CyPath Diagnostic Assay - Lung Cancer - Product Status 47
CyPath Diagnostic Assay - Lung Cancer - Product Description 47
CyPath Diagnostic Assay - Lung Cancer - Product Milestone 47
CyPath Diagnostic Assay - Lung Cancer - Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer 48
CyPath Diagnostic Assay - Lung Cancer - A Multi-center Study To Evaluate The Biomoda CyPath Early Lung Cancer Detection Assay 49
CyPath Diagnostic Assay - Lung Cancer - Patent Details1 50
CyPath Diagnostic Assay - Lung Cancer - Patent Details2 51
CyPath Diagnostic Assay - Lung Cancer - Patent Details3 51
CyPath Diagnostic Assay - Lung Cancer - Patent Details4 52
CyPath Diagnostic Assay - Lung Cancer - Patent Details5 52
CyPath Diagnostic Assay - Lung Cancer - Patent Details6 53
CyPath Diagnostic Assay - Lung Cancer - Patent Details7 53
CyPath Diagnostic Assay - Lung Cancer - Patent Details8 54
CyPath Diagnostic Assay - Lung Cancer - Patent Details9 54
CyPath Diagnostic Assay - Lung Cancer - Patent Details10 55
CyPath Diagnostic Assay - Oral Cancer - Product Status 56
CyPath Diagnostic Assay - Oral Cancer - Product Description 56
CyPath Diagnostic Assay - Oral Cancer - Patent Details1 56
CyPath Diagnostic Assay - Oral Cancer - Patent Details2 57
CyPath Diagnostic Assay - Oral Cancer - Patent Details3 57
CyPath Diagnostic Assay - Oral Cancer - Patent Details4 58
CyPath Diagnostic Assay - Oral Cancer - Patent Details5 58
CyPath Diagnostic Assay - Oral Cancer - Patent Details6 59
CyPath Diagnostic Assay - Oral Cancer - Patent Details7 59
CyPath Diagnostic Assay - Oral Cancer - Patent Details8 60
CyPath Diagnostic Assay - Oral Cancer - Patent Details9 60
Biomoda, Inc., Key Employees 63

List of Chart


Biomoda, Inc. Pipeline Products by Equipment Type 8
Biomoda, Inc. Pipeline Products by Development Stage 10
Biomoda, Inc. Pipeline Products by Therapy Area 12
Biomoda, Inc. Pipeline Products by Trial Phase 14
Biomoda, Inc. Pipeline Products by Milestone Summary 16

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *